APA (7th ed.) Citation

S, L., SJ, Y., J, L., JH, O., JS, R., G, K., . . . ES, H. (2026). PoMA-10: A dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue. Frontiers in pharmacology, 17, 1755268. https://doi.org/10.3389/fphar.2026.1755268

Chicago Style (17th ed.) Citation

S, Lee, et al. "PoMA-10: A Dual-action Antiviral Disrupting SARS-CoV-2 Spike-ACE2 Interaction and Protecting Lung Tissue." Frontiers in Pharmacology 17 (2026): 1755268. https://doi.org/10.3389/fphar.2026.1755268.

MLA (9th ed.) Citation

S, Lee, et al. "PoMA-10: A Dual-action Antiviral Disrupting SARS-CoV-2 Spike-ACE2 Interaction and Protecting Lung Tissue." Frontiers in Pharmacology, vol. 17, 2026, p. 1755268, https://doi.org/10.3389/fphar.2026.1755268.